Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12497256 | 0.88 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL14720690 | 0.86 | KMT2A (0.45) | SRD5A2ALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL14720705 | 0.81 | ALDH1A1 (0.44) | SRD5A2ALDH1A1L3MBTL1TSHRKDM4E | |
| SCHEMBL6194728 | 0.79 | OGA (0.50) | SRD5A2ALDH1A1TSHRHDAC2 | |
| SCHEMBL12497138 | 0.78 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL6392680 | 0.78 | SRD5A1 (0.50) | SRD5A2ALDH1A1TSHRKMT2AKDM4E | |
| SCHEMBL12497730 | 0.76 | NR1H2 (0.42) | ALDH1A1L3MBTL1MEN1KMT2AKDM4E | |
| SCHEMBL9137801 | 0.76 | POLB (0.43) | SRD5A2ALDH1A1MEN1KMT2A | |
| SCHEMBL9139619 | 0.76 | SRD5A2 (0.47) | SRD5A2ALDH1A1MEN1KMT2AHSP90AA1 | |
| SCHEMBL9138031 | 0.76 | SRD5A2 (0.53) | SRD5A2ALDH1A1L3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |